Long Noncoding RNAs and Circular RNAs Regulate AKT and Its Effectors to Control Cell Functions of Cancer Cells

Jen-Yang Tang1,2, Ya-Ting Chuang3, Jun-Ping Shiau4

  • 1School of Post-Baccalaureate Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.

Cells
|October 14, 2022
PubMed

Insights

Long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) regulate cancer cell functions by modulating AKT serine-threonine kinase (AKT) and its effectors. This review explores their complex interplay, revealing a network connecting these molecules to critical cellular processes.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • AKT serine-threonine kinase (AKT) and its effectors are crucial regulators of fundamental cancer cell processes, including proliferation, apoptosis, autophagy, and migration.
  • Long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) are increasingly recognized for their roles in gene expression regulation and cellular functions.
  • The specific mechanisms by which lncRNAs and circRNAs influence AKT signaling pathways and their downstream effectors in cancer remain incompletely understood.

Purpose of the Study:

  • To comprehensively review the current understanding of the relationship between lncRNAs, circRNAs, AKT, and its effectors in regulating cancer cell functions.
  • To explore the roles of specific lncRNAs and circRNAs that target key AKT effectors, such as FOXO, mTORC1/2, S6K1/2, 4EBP1, SREBP, and HIF.
  • To provide insights into the intricate network connecting these molecules and their impact on cancer cell biology.

Main Methods:

  • Literature survey and in-depth review of existing research on lncRNAs, circRNAs, AKT signaling, and cancer cell functions.
  • Retrieval and analysis of predicted AKT- and AKT effector-targeting lncRNAs and circRNAs from databases like LncTarD and circBase.
  • Integration of database findings with literature data to establish connections between these regulatory elements and cellular processes.

Main Results:

  • Several lncRNAs and circRNAs have been identified to modulate the activity of AKT and its key effectors, influencing critical cancer cell functions.
  • Database analysis and literature review confirm a significant association between these non-coding RNAs and the regulation of AKT-mediated cellular processes.
  • The identified lncRNAs and circRNAs play diverse roles in processes such as proliferation, apoptosis, ER stress, and migration of cancer cells.

Conclusions:

  • lncRNAs and circRNAs are significant regulators of cancer cell functions through their modulation of the AKT signaling pathway and its effectors.
  • A complex regulatory network exists, linking AKT, its effectors, lncRNAs, and circRNAs, offering potential therapeutic targets in cancer.
  • Further research is warranted to fully elucidate the specific mechanisms and therapeutic implications of this intricate molecular interplay.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
979
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.6K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
6.1K